Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple patch save older women from strokes?

NCT ID NCT05444335

First seen Jan 24, 2026 · Last updated Jun 23, 2026 · Updated 19 times

Summary

This study is testing whether a wearable heart monitor (Zio patch) worn for two weeks can detect undiagnosed atrial fibrillation in women aged 70 and older. Atrial fibrillation is a common heart rhythm problem that raises stroke risk, especially in older women. The goal is to see how many women have this condition and whether they then receive blood thinners to prevent strokes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION NEW ONSET are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Maryland Medical Center

    Baltimore, Maryland, 21201, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Zio patch wearable cardiac monitor

What this could lead to

If successful, this could show that routine screening with a wearable monitor helps detect hidden atrial fibrillation in older women, potentially reducing their stroke risk.

What could go wrong

This is a small pilot study with only 120 participants, so results may not apply to all older women. The device may be uncomfortable or not worn as directed, and detecting Afib doesn't guarantee better outcomes.

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.